Wed, October 4, 2023
Tue, October 3, 2023
Mon, October 2, 2023
Sun, October 1, 2023
Fri, September 29, 2023
Thu, September 28, 2023
Wed, September 27, 2023

Joanne Wuensch Maintained (ABT) at Strong Buy with Decreased Target to $122 on, Oct 2nd, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-122-on-oct-2nd-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Joanne Wuensch of Citigroup, Maintained "Abbott Laboratories" (ABT) at Strong Buy with Decreased Target from $130 to $122 on, Oct 2nd, 2023.

Joanne has made no other calls on ABT in the last 4 months.



There are 4 other peers that have a rating on ABT. Out of the 4 peers that are also analyzing ABT, 3 agree with Joanne's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Mike Polark of "Wolfe Research" Upgraded from Sell to Hold on, Friday, July 21st, 2023
  • Anthony Petrone of "Mizuho" Initiated at Hold with Increased Target to $115 on, Friday, July 21st, 2023
  • David Lewis of "Morgan Stanley" Reiterated at Hold and Held Target at $112 on, Friday, July 21st, 2023


This is the rating of the analyst that currently disagrees with Joanne


  • Matt Miksic of "Barclays" Maintained at Buy with Increased Target to $132 on, Monday, July 24th, 2023

Publication Contributing Sources